Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul;11(7):770-780.
doi: 10.1002/1878-0261.12081. Epub 2017 Jun 9.

Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells

Douglas S Micalizzi  1   2 , Daniel A Haber  1   2   3 , Shyamala Maheswaran  1   4
Affiliations
Review

Cancer metastasis through the prism of epithelial-to-mesenchymal transition in circulating tumor cells

Douglas S Micalizzi et al. Mol Oncol. 2017 Jul.

Abstract

Metastasis of epithelial cancer cells to distant sites is a particularly critical stage of cancer progression that typically marks the incurability of the disease. It is governed by a complex series of events including invasion and intravasation of tumor cells into the stroma and blood, respectively. Epithelial-to-mesenchymal transition (EMT), a phenotypic change marked by the loss of epithelial characteristics and the acquisition of invasive mesenchymal properties, is implicated in the dissemination of tumor cells. Circulating tumor cells (CTCs), the precursors of metastasis, can be used to interrogate the contribution of EMT in metastasis and therapeutic responses. The analysis of these CTCs and in particular the presence of inter- and intrapatient heterogeneity for markers of EMT has provided new insights into the metastatic process. This review will focus on epithelial-mesenchymal plasticity in CTCs and its potential clinical implications.

Keywords: cancer; circulating tumor cells; epithelial to mesenchymal transition; metastasis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Epithelial‐to‐mesenchymal transition (EMT) in circulating tumor cells (CTCs): Invasive cells from the primary tumor exhibit epithelial plasticity including the loss of epithelial markers and gain of mesenchymal markers. Solitary and clusters of CTCs demonstrate heterogeneity of epithelial and mesenchymal markers.
Figure 2
Figure 2
Heterogeneity of CTCs in metastatic disease: CTCs represent the intrapatient tumor heterogeneity of cancer cells residing at multiple metastatic sites.
See this image and copyright information in PMC

References

    1. Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H et al (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110–1122. - PMC - PubMed
    1. Aktas B, Tewes M, Fehm T, Hauch S, Kimmig R and Kasimir‐Bauer S (2009) Stem cell and epithelial‐mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients. Breast Cancer Res 11, R46. - PMC - PubMed
    1. Alexaki VI, Javelaud D, Van Kempen LC, Mohammad KS, Dennler S, Luciani F, Hoek KS, Juarez P, Goydos JS, Fournier PJ et al (2010) GLI2‐mediated melanoma invasion and metastasis. J Natl Cancer Inst 102, 1148–1159. - PMC - PubMed
    1. Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW and Terstappen LW (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10, 6897–6904. - PubMed
    1. Alonso SR, Tracey L, Ortiz P, Perez‐Gomez B, Palacios J, Pollan M, Linares J, Serrano S, Saez‐Castillo AI, Sanchez L et al (2007) A high‐throughput study in melanoma identifies epithelial‐mesenchymal transition as a major determinant of metastasis. Cancer Res 67, 3450–3460. - PubMed

Publication types

MeSH terms

LinkOut - more resources